News
EQS-News: Leifheit AG enters the dust segment with the new product innovation SUPERDUSTER
AUSTRIACARD HOLDINGS presents new AI-driven Anti-Money Laundering solution at Money 20/20
EQS-News: Announcement according to Section § 65 (1b) of the Stock Corporation Act in connection with Section 119 (7) of the Stock Exchange Act and Sections 2 and 3 of the Austrian Publication Ordinance
Seventh and Eighth O3b mPOWER Satellites to Start Delivering Connectivity Services
SES announced today that the latest pair of O3b mPOWER satellites launched in December 2024 is now ready to offer services across the globe.
Featuring redesigned payload power modules, the
EQS-News: UNIQA Insurance Group AG: Dividend Announcement
Philip Morris International Participates in dbAccess Global Consumer Conference
Regulatory News:
Philip Morris International Inc.’s (PMI) (NYSE: PM) Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2025 dbAccess Global Consumer Conference in
EQS-News: Independent DNV study confirms significant advantages of CERENERGY sodium chloride solid-state batteries over other stationary battery storage technologies
EQS-News: swissnet Group Enters New Strategic Partnership with Clemenceau Medical Center Hospital, a Leading Multinational Hospital Chain in Dubai
EQS-News: wienerberger acquires MFP in Ireland and strengthens position in key growth markets
EQS-News: DATAGROUP accompanies Degussa Goldhandel on the path to growth
BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 2025
Cicor closes strategic partnership with Mercury and strengthens market leadership in the European defence sector
Sensirion Connected Solutions acquires Kuva Systems to expand methane emissions monitoring portfolio
Highlight Event and Entertainment AG publishes invitation to the Annual General meeting on 25 June 2025
Pembina Pipeline Corporation Announces $200 Million Subordinated Note Offering
Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) announced today that it has agreed to issue $200 million aggregate principal amount of 5.95% Fixed-to-Fixed Rate
Alcoa Releases 2024 Sustainability Report
Alcoa Corporation (NYSE: AA, ASX: AAI) has issued its 2024 Sustainability Report. The report outlines Alcoa’s approach to sustainability as it relates to building resiliency within its global
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced the presentation of new clinical results from the PREDICT DNA and SCANDARE studies highlighting the
Essential Properties Realty Trust, Inc. Increases Quarterly Dividend to $0.30 per Share, an Increase of Approximately 2% Over Prior Quarter
Essential Properties Realty Trust, Inc. (NYSE: EPRT; the “Company”) announced today that its Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock for the second
QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease
EQS-Adhoc: PIERER Mobility AG: Changes to the Supervisory Board
EQS-News: Abivax Presents First Quarter 2025 Financial Results
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for May 2025, includes Reg.-NMS Execution Statistics
Interactive Brokers Group, Inc. (Nasdaq: IBKR) an automated global electronic broker, today reported its Electronic Brokerage monthly performance metrics for May.
Brokerage highlights for the
MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to